Guo et al., 2016 - Google Patents
A single injection of recombinant adeno-associated virus into the lumbar cistern delivers transgene expression throughout the whole spinal cordGuo et al., 2016
View HTML- Document ID
- 9367057986809987962
- Author
- Guo Y
- Wang D
- Qiao T
- Yang C
- Su Q
- Gao G
- Xu Z
- Publication year
- Publication venue
- Molecular neurobiology
External Links
Snippet
The lack of methods to deliver transgene expression in spinal cord has hampered investigation of gene function and therapeutic targets for spinal cord diseases. Here, we report that a single intrathecal injection of recombinant adeno-associated virus rhesus-10 …
- 210000000278 Spinal Cord 0 title abstract description 78
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA Viruses
- C12N2750/00011—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA Viruses ssDNA Viruses
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
- A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
- A61K49/0414—Particles, beads, capsules or spheres
- A61K49/0423—Nanoparticles, nanobeads, nanospheres, nanocapsules, i.e. having a size or diameter smaller than 1 micrometer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
- A01K67/027—New breeds of vertebrates
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Guo et al. | A single injection of recombinant adeno-associated virus into the lumbar cistern delivers transgene expression throughout the whole spinal cord | |
Schuster et al. | Biodistribution of adeno-associated virus serotype 9 (AAV9) vector after intrathecal and intravenous delivery in mouse | |
JP6887008B2 (en) | Gene therapy for spinal cord disease | |
US20230332179A1 (en) | Cns targeting aav vectors and methods of use thereof | |
Aschauer et al. | Analysis of transduction efficiency, tropism and axonal transport of AAV serotypes 1, 2, 5, 6, 8 and 9 in the mouse brain | |
Kilpatrick et al. | Adeno-associated virus-mediated gene delivery into the scala media of the normal and deafened adult mouse ear | |
Passini et al. | Intracranial delivery of CLN2 reduces brain pathology in a mouse model of classical late infantile neuronal ceroid lipofuscinosis | |
Hordeaux et al. | Efficient central nervous system AAVrh10-mediated intrathecal gene transfer in adult and neonate rats | |
ES2904504T3 (en) | Improved delivery of viral particles to the striatum and cortex | |
Hsu et al. | Noninvasive and targeted gene delivery into the brain using microbubble-facilitated focused ultrasound | |
Vite et al. | Adeno-associated virus vector-mediated transduction in the cat brain | |
Orefice et al. | Real-time monitoring of exosome enveloped-AAV spreading by endomicroscopy approach: a new tool for gene delivery in the brain | |
Hordeaux et al. | Efficacy and safety of a Krabbe disease gene therapy | |
Blesa et al. | BBB opening with focused ultrasound in nonhuman primates and Parkinson’s disease patients: Targeted AAV vector delivery and PET imaging | |
Swain et al. | Adeno-associated virus serotypes 9 and rh10 mediate strong neuronal transduction of the dog brain | |
Zubair et al. | Divergent whole brain projections from the ventral midbrain in macaques | |
Pietersz et al. | Transduction patterns in the CNS following various routes of AAV-5-mediated gene delivery | |
Galvan et al. | Intracerebroventricular administration of AAV9-PHP. B SYN1-EmGFP induces widespread transgene expression in the mouse and monkey central nervous system | |
Liu et al. | Use of self-complementary adeno-associated virus serotype 2 as a tracer for labeling axons: implications for axon regeneration | |
Yoon et al. | Global CNS correction in a large brain model of human alpha-mannosidosis by intravascular gene therapy | |
Schuster et al. | Supraspinal gene transfer by intrathecal adeno-associated virus serotype 5 | |
Hu et al. | Widespread labeling and genomic editing of the fetal central nervous system by in utero CRISPR AAV9-PHP. eB administration | |
Iwamoto et al. | Global diffuse distribution in the brain and efficient gene delivery to the dorsal root ganglia by intrathecal injection of adeno‐associated viral vector serotype 1 | |
Menon et al. | Viral alpha-synuclein knockdown prevents spreading synucleinopathy | |
Fomenko et al. | Deep brain stimulation of the medial septal nucleus induces expression of a virally delivered reporter gene in dentate gyrus |